Initiator+ Alstra™ Microwave Peptide Synthesizer, US/JP configuration, including an Alstra trade-in

The NIH intends to award a firm‑fixed‑price purchase order for a Biotage Initiator+ Alstra™ microwave peptide synthesizer (US/JP configuration) with a trade‑in of an existing Alstra system. The agency has identified Biotage as the only source capable of meeting the highly specific technical requirements (proprietary digital syringe pump, dual‑needle technology, oscillatory mixing, vacuum‑pump fluid transfer, and dedicated software). Because the NIH’s current peptide synthesis workflows depend on these proprietary features, substitution would require costly revalidation. Interested parties may submit a capability statement by the deadline; the NIH will decide whether to proceed as a single‑source award or open competition. The award is expected within five days after the submission deadline. • Single‑source procurement under FAR 6.302‑1. • Equipment: microwave peptide synthesizer with trade‑in. • Required capability statement due 9:00 a.m. EDT, August 31 2026. • Award anticipated ~September 5 2026. • No competition unless another qualified source is identified.